For the year ending 2025-12-31, VIR made $68,556K in revenue. -$437,987K in net income. Net profit margin of -638.87%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 68,556 | 63,712 | ||
| Cost of revenue | 26 | 845 | ||
| Research and development | 455,966 | 506,499 | ||
| Selling, general and administrative | 92,074 | 119,031 | ||
| Restructuring, long-lived assets impairment and related charges, net | -182 | 34,995 | ||
| Total operating expenses | 547,884 | 661,370 | ||
| Loss from operations | -479,328 | -587,165 | ||
| Change in fair value of equity investments | 1,729 | -5,528 | ||
| Interest income | 40,238 | 71,809 | ||
| Other expense, net | -409 | -2,221 | ||
| Total other income | 41,558 | 64,060 | ||
| Loss before (provision for) benefit from income taxes | -437,770 | -523,105 | ||
| (provision for) benefit from income taxes | 217 | -1,145 | ||
| Net loss | -437,987 | -521,960 | ||
| Net loss attributable to noncontrolling interest | 0 | - | ||
| Net loss attributable to vir bio | -437,987 | -521,960 | ||
| Basic EPS | -3.16 | -3.83 | ||
| Diluted EPS | -3.16 | -3.83 | ||
| Basic Average Shares | 138,520,419 | 136,246,865 | ||
| Diluted Average Shares | 138,520,419 | 136,246,865 | ||
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)